HUTCHMED (China) Limited (HCM) RNS Announcements

Add to Alert list
Date Time Source Announcement
26 Jul 2006 10:00 AM
RNS
Notice of Results
17 Jul 2006 07:00 AM
RNS
Trading Update
04 Jul 2006 07:00 AM
RNS
Clinical Update
19 May 2006 10:47 AM
RNS
Director/PDMR Shareholding
19 May 2006 07:00 AM
RNS
First Day Trading

Hutchmed China  Limited develops, manufactures, and sells pharmaceutical products. The Company offers drugs for oncology and autoimmune diseases treatment. HUTCHMED (China) is headquartered in Hong Kong and markets its products worldwide.

It was founded in 2000 and listed in London in 2018 under the ticker HCM. 

UK 100